These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

132 related items for PubMed ID: 1448774

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. The comparative effects of recombinant hirudin (CGP 39393) and standard heparin on thrombus growth in rabbits.
    Agnelli G, Pascucci C, Cosmi B, Nenci GG.
    Thromb Haemost; 1990 Apr 12; 63(2):204-7. PubMed ID: 2363121
    [Abstract] [Full Text] [Related]

  • 4. The effect of antithrombin III-independent thrombin inhibitors and heparin on fibrin accretion onto fibrin-coated polyethylene.
    Rubens FD, Weitz JI, Brash JL, Kinlough-Rathbone RL.
    Thromb Haemost; 1993 Feb 01; 69(2):130-4. PubMed ID: 8456425
    [Abstract] [Full Text] [Related]

  • 5. Sustained antithrombotic activity of hirudin after its plasma clearance: comparison with heparin.
    Agnelli G, Renga C, Weitz JI, Nenci GG, Hirsh J.
    Blood; 1992 Aug 15; 80(4):960-5. PubMed ID: 1498336
    [Abstract] [Full Text] [Related]

  • 6. The effects of heparin and annexin V on fibrin accretion after injury in the jugular veins of rabbits.
    Van Ryn-McKenna J, Merk H, Müller TH, Buchanan MR, Eisert WG.
    Thromb Haemost; 1993 Mar 01; 69(3):227-30. PubMed ID: 8470045
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Fibrin moderates the catalytic action of heparin but not that of dermatan sulfate on thrombin inhibition in human plasma.
    Okwusidi JI, Anvari N, Kulczycky M, Blajchman MA, Buchanan MR, Ofosu FA.
    J Lab Clin Med; 1991 May 01; 117(5):359-64. PubMed ID: 2019790
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Reactivation of coagulation after stopping infusions of recombinant hirudin and unfractionated heparin in unstable angina and myocardial infarction without ST elevation: results of a randomized trial. OASIS Pilot Study Investigators. Organization to Assess Strategies for Ischemic++ Syndromes.
    Flather MD, Weitz JI, Yusuf S, Pogue J, Sussex B, Campeau J, Gill J, Schuld R, Joyner CD, Morris AL, Lai C, Théroux P, Marquis JF, Chan YK, Venkatesh G, Jessel A.
    Eur Heart J; 2000 Sep 01; 21(17):1473-81. PubMed ID: 10952840
    [Abstract] [Full Text] [Related]

  • 11. Affects of hirudin and heparin on the binding of new fibrin to the thrombus in t-PA treated rabbits.
    Agnelli G, Pascucci C, Cosmi B, Nenci GG.
    Thromb Haemost; 1991 Nov 01; 66(5):592-7. PubMed ID: 1839474
    [Abstract] [Full Text] [Related]

  • 12. [Antithrombin therapy in acute coronary syndromes].
    Maseri A, Andreotti F, Biasucci LM, Rebuzzi AG.
    Cardiologia; 1994 Dec 01; 39(12 Suppl 1):7-13. PubMed ID: 7634317
    [Abstract] [Full Text] [Related]

  • 13. [The importance of thrombin and its inhibition in unstable angina. Nonfractionated heparin, hirudin and defractionated heparins].
    López-Sendón J, López de Sá E, Rubio Sanz R, Delcán Domínguez JL.
    Rev Esp Cardiol; 1999 Dec 01; 52 Suppl 1():76-89. PubMed ID: 10364817
    [Abstract] [Full Text] [Related]

  • 14. Platelet deposition induced by severely damaged vessel wall is inhibited by a boroarginine synthetic peptide with antithrombin activity.
    Badimon JJ, Weng D, Chesebro JH, Fuster V, Badimon L.
    Thromb Haemost; 1994 Apr 01; 71(4):511-6. PubMed ID: 8052972
    [Abstract] [Full Text] [Related]

  • 15. Effects of sulfated polysaccharides on inhibition of thrombus formation initiated by different stimuli.
    Van Ryn-McKenna J, Gray E, Weber E, Ofosu FA, Buchanan MR.
    Thromb Haemost; 1989 Feb 28; 61(1):7-9. PubMed ID: 2473537
    [Abstract] [Full Text] [Related]

  • 16. Clot-bound thrombin is protected from inhibition by heparin-antithrombin III but is susceptible to inactivation by antithrombin III-independent inhibitors.
    Weitz JI, Hudoba M, Massel D, Maraganore J, Hirsh J.
    J Clin Invest; 1990 Aug 28; 86(2):385-91. PubMed ID: 2384594
    [Abstract] [Full Text] [Related]

  • 17. Experimental thrombosis on a collagen coated arterioarterial shunt in rats: a pharmacological model to study antithrombotic agents inhibiting thrombin formation and platelet deposition.
    Freund M, Mantz F, Nicolini P, Gachet C, Mulvihill J, Meyer L, Beretz A, Cazenave JP.
    Thromb Haemost; 1993 May 03; 69(5):515-21. PubMed ID: 8322274
    [Abstract] [Full Text] [Related]

  • 18. Catalysis of thrombin inhibition provides an index for estimating the antithrombotic potential of glycosaminoglycans in rabbits.
    Fernandez FA, Buchanan MR, Hirsh J, Fenton JW, Ofosu FA.
    Thromb Haemost; 1987 Jun 03; 57(3):286-93. PubMed ID: 3116701
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Effects of heparin, its low molecular weight fractions and other glycosaminoglycans on thrombus growth in vivo.
    Boneu B, Buchanan MR, Cade JF, Van Ryn J, Fernandez FF, Ofosu FA, Hirsh J.
    Thromb Res; 1985 Oct 01; 40(1):81-9. PubMed ID: 4089829
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.